UNSPSC 51141596: Phenytoin sodium

This classification denotes a cation channel blocker and anticonvulsant agent with the molecular formula C15H11N2O2.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4182431BJH, chemically known as 5,5-diphenylhydantoin sodium salt but more generally known as diphenylhydantoin sodium, which bears US NIH Compound Identifier 12425. European Medicines Agency schedules Phenytoin sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03787MIG.

Most nations, for tariff and trade purposes, schedule phenytoin sodium under HS 29332100 and SITC 51572. As of Q4 2014, PHENYTOIN SODIUM remains US FDA's Preferred Term for this commodity. Phenytoin sodium bears US NLM identifiers UMLS ID C0237417 and NCI Concept Code C48011. SMILES: C1CCC(CC1)C2(C(=O)[N-]C(=O)N2)C3CCCCC3.[NA+].

UNSPSC 51141596 Phenytoin sodium is a Commodity code that should track pharmaceutical products used in seizure management and neurological treatment, but the recent state and local procurement activity does not align with this nominal scope. The single recent opportunity posted under this code—Seminole County, Florida's IFB60459723LAS for naloxone and drug deactivation systems—represents emergency response and harm-reduction products rather than anticonvulsant medications. This mismatch suggests either a coding error in the county's procurement system or broader tagging practice that does not reflect actual pharmaceutical categories being purchased. State and local health departments, county community health programs, and municipalities do procure seizure-management medications and anticonvulsants through similar mechanisms (IFB and RFQ processes, quarterly or annual contract terms, fixed-fee pricing), but the available record does not surface recent opportunities for phenytoin sodium or related products under this code.

The Seminole County opportunity, posted June 30, 2026 with an IFB response deadline of July 26, 2023, required annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The county mandated electronic bid submission through its e-Procurement Portal, E-Verify compliance, drug-free workplace certification, and specified insurance coverage; the contract included a two-year initial term with one-year renewal option and potential FEMA funding with associated federal compliance requirements. No other recent state or local opportunities for phenytoin sodium or related anticonvulsant medications appear in the current activity set. Code users should verify whether opportunities for actual phenytoin sodium procurement are tagged differently in their target jurisdictions or monitor this code for correction and future pharmaceutical-aligned activity.